H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 16.06 HKD 0.37% Market Closed
Updated: May 31, 2024

Income Statement

Earnings Waterfall
Hansoh Pharmaceutical Group Company Ltd

Revenue
10.1B CNY
Cost of Revenue
-1B CNY
Gross Profit
9.1B CNY
Operating Expenses
-6.4B CNY
Operating Income
2.6B CNY
Other Expenses
631m CNY
Net Income
3.3B CNY

Income Statement
Hansoh Pharmaceutical Group Company Ltd

Rotate your device to view
Income Statement
Currency: CNY
Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Revenue
Revenue
8 683
N/A
8 063
-7%
8 690
+8%
9 112
+5%
9 935
+9%
9 968
+0%
9 382
-6%
9 459
+1%
10 104
+7%
Gross Profit
Cost of Revenue
(730)
(705)
(803)
(859)
(870)
(853)
(870)
(1 002)
(1 033)
Gross Profit
7 953
N/A
7 357
-7%
7 887
+7%
8 253
+5%
9 065
+10%
9 115
+1%
8 512
-7%
8 457
-1%
9 071
+7%
Operating Income
Operating Expenses
(5 155)
(4 667)
(5 103)
(5 399)
(6 105)
(6 312)
(5 947)
(6 077)
(6 425)
Selling, General & Administrative
(4 043)
(3 639)
(3 861)
(4 027)
(4 372)
(4 387)
(4 155)
(4 184)
(4 263)
Research & Development
(1 121)
(1 039)
(1 252)
(1 463)
(1 797)
(1 849)
(1 693)
(1 884)
(2 097)
Other Operating Expenses
8
12
11
90
64
(76)
(99)
(9)
(64)
Operating Income
2 798
N/A
2 691
-4%
2 784
+3%
2 854
+3%
2 960
+4%
2 803
-5%
2 566
-8%
2 380
-7%
2 647
+11%
Pre-Tax Income
Interest Income Expense
212
274
315
294
336
453
372
545
1 107
Non-Reccuring Items
(9)
(15)
(0)
4
4
6
11
15
13
Pre-Tax Income
3 001
N/A
2 949
-2%
3 098
+5%
3 152
+2%
3 300
+5%
3 262
-1%
2 948
-10%
2 939
0%
3 766
+28%
Net Income
Tax Provision
(444)
(467)
(529)
(514)
(587)
(542)
(365)
(365)
(489)
Income from Continuing Operations
2 557
2 483
2 569
2 638
2 713
2 720
2 584
2 575
3 278
Net Income (Common)
2 557
N/A
2 483
-3%
2 569
+3%
2 638
+3%
2 713
+3%
2 720
+0%
2 584
-5%
2 575
0%
3 278
+27%
EPS (Diluted)
0.47
N/A
0.43
-9%
0.44
+2%
0.43
-2%
0.44
+2%
0.46
+5%
0.44
-4%
0.43
-2%
0.54
+26%

See Also

Discover More